Carescape Canvas 1000; Carescape Canvas Smart Display
GE Healthcare Finland Oy · Decision date Aug 28, 2026
What did the FDA decide?
FDA records K260343 as a 510(k) premarket notification, with a decision dated Aug 28, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Cardiovascular
- Decision date
- Aug 28, 2026
Regulatory record facts
- Identifier
- K260343
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- GE Healthcare Finland Oy
- Product code
- MHX
- Decision code
- SESE
- Decision date
- Aug 28, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Monitor, Physiological, Patient(With Arrhythmia Detection Or Alarms).
- Applicant
- GE Healthcare Finland Oy
- Product code
- MHX
- FDA device class
- 2
FDA decision timeline
K260343 received
Application receipt date recorded by FDA.
K260343 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code MHX
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
12SL PrecisionK261307 | Ge Medical Systems Information Technologies, Inc. | 510(k) clearance | Nov 3, 2026 | FDA |
Radius VSM and AccessoriesK260676 | Masimo Corporation | 510(k) clearance | Oct 14, 2026 | FDA |
| GE Healthcare Finland Oy | 510(k) clearance | Sep 1, 2026 | FDA | |
| Draeger Medical Systems, Inc. | 510(k) clearance | Aug 20, 2026 | FDA | |
| Edan Instruments, Inc. | 510(k) clearance | Aug 6, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
GE Healthcare Finland Oy
- Headquarters
- Not reported
- Brand website
- gehealthcare.com
- FDA applicant address
- Helsinki
Sources and methodology
- Original FDA record: K260343
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records


